Olympus Expands Investment, Partnership with Cytori Therapeutics in Regenerative Medecine.Tokyo, Japan, Aug 26, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Olympus Corporation This article refers to a Japanese camera maker. For other meanings, see Olympus (disambiguation). Olympus Corporation (オリンパス株式会社 , which recently acquired shares worth approximately $11 million in San Diego San Diego (săn dēā`gō), city (1990 pop. 1,110,549), seat of San Diego co., S Calif., on San Diego Bay; inc. 1850. San Diego includes the unincorporated communities of La Jolla and Spring Valley. Coronado is across the bay. based Cytori Therapeutics, has announced plans to accelerate investment and expand its partnership with the American company. Cytori Therapeutics carries out research focusing on stem and regenerative re·gen·er·a·tive adj. 1. Of, relating to, or marked by regeneration. 2. Tending to regenerate. re·gen cells derived from adipose tissue adipose tissue (ăd`əpōs'): see connective tissue. adipose tissue or fatty tissue Connective tissue consisting mainly of fat cells, specialized to synthesize and contain large globules of fat, within a , commonly known as fat. In December 2005, Olympus and Cytori established a joint venture to commence development of a new system to process adipose-derived stem and regenerative cells for use in regenerative medicine. By expanding the investment in the company, Olympus aims to accelerate the commercialization of regenerative medicine treatments based on adipose-derived stem and regenerative cells. The strategy also encompasses the commercialization of an adipose-derived stem and regenerative cell processing system. A second aim of the investment is to speed up the development of the next-generation system through Olympus-Cytori, Inc., a joint venture also located in San Diego, which will manufacture the commercial version of the system. Olumpus hopes to commence sales of an automated high quality system with improved operating performance within two to four years, depending on legal and regulatory requirements in the countries concerned. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion